Skip to main content
. 2022 Oct 20;4(10):e0780. doi: 10.1097/CCE.0000000000000780

TABLE 2.

Clinical Course and Outcomes of the Study Participants

Outcome Total (N = 111) ARDS (N = 21; 18.9%) Non-ARDS (N = 90; 81.1%) p
Vasopressor requirement, n (%) 84 (75.7) 17 (81.0) 67 (74.4) 0.53a
Renal replacement therapy, n (%) 27 (24.3) 3 (14.3) 24 (26.7) 0.23a
Invasive mechanical ventilation, n (%) 79 (71.2) 20 (95.2) 59 (65.6) 0.007a
Initial tidal volume per ideal body weight (mL/kg), median (IQR) 6.21 (5.85–6.95) 5.88 (5.43–6.53) 6.26 (5.92–7.04) 0.08b
Initial positive end-expiratory pressure (cm H2O), median (IQR) 8 (8) 8 (8–12) 8 (8) 0.01b
Worst Pao2/Fio2 ratio, median (IQR) 132 (181–250) 118 (78–166) 202 (143–262) < 0.001b
Mortality, n (%) 45 (40.5) 10 (47.6) 35 (38.9) 0.46a
28-d ventilator-free days (d), median (IQR) 19 (2–26) 8 (0–22) 20.5 (6–28) 0.02b
28-d ICU-free days (days), median (IQR) 15 (0–24) 1 (0–21) 16.5 (3–24) 0.02b

ARDS = acute respiratory distress syndrome, IQR = interquartile range.

aχ2.

bWilcoxon rank-sum test were used to calculate the p values.